Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

China to downgrade COVID-19 management to Class B

BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers fromJan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National...

2022-12-27 18:06 2255

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...

2022-12-27 10:00 3357

China actively optimizes COVID-19 response measures to better prepare for challenges

BEIJING, Dec. 26, 2022 /PRNewswire/ -- As multiple regions in China have seen surging COVID-19 infections, local governments are taking swift and precise measures to prevent severe cases, protect people's health, and build a barrier against the epidemic. These measures include providing timely m...

2022-12-26 14:32 3148

CGTN: 'New Approaches': How China stepped up its COVID-19 treatments

BEIJING, Dec. 21, 2022 /PRNewswire/ -- China has been racing against the clock in developing COVID-19 drugs while promoting vaccination – one for saving lives and the other for providing broad protection. While the stringent COVID-19 containment measures of the past three years helpedChina evade...

2022-12-21 18:51 2184

CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation

BEIJING, Dec. 20, 2022 /PRNewswire/ -- China now has been enhancing its COVID-19 vaccination as a priority especially among the vulnerable groups such as elders to further cement its protection for people against the virus. This strategy is becoming more prominent as the country has loosened up i...

2022-12-20 22:53 2547

CGTN: New Approaches: Why China is easing its COVID-19 curbs now

BEIJING, Dec. 20, 2022 /PRNewswire/ -- SARS-CoV-2, the virus causing COVID-19, mutates constantly. Since the beginning of the pandemic three years ago, the virus has hit the world with different faces – Alpha, Beta, Delta, Gamma and then Omicron – taking away millions of lives. Wu Zunyou, chief ...

2022-12-20 10:59 1925

Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines

TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, fr...

2022-12-19 13:53 2088

Bioved Pharmaceuticals, Inc. announces the results of its Phase III Randomized Clinical Trial in Moderate Covid-19 with Artovid-20®, a natural plant-based oral product

SAN JOSE, Calif., Dec. 16, 2022 /PRNewswire/ -- Published Nov 25, 2022 in the highly respected peer-reviewed journal Phytotherapy Research, results show statistically significant reduction in duration of illness and severity scores of the symptoms associated with Covid-19. In addition, statistica...

2022-12-16 01:30 1920

Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes

GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed offering of$125 million aggregate principal amount of convertible...

2022-12-15 23:43 3399

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children's Cancers

ACC, NCCN, ACS, and CHAI collaborate to launch new NCCN Harmonized Guidelines for Sub-Saharan Africa focused on pediatric cancers; available free at NCCN.org/harmonized. DAR ES SALAAM, Tanzania and PLYMOUTH MEETING, Pa., Dec. 15, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NC...

2022-12-15 14:07 1641

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children's Cancers

Stemirna receives Emergency Use Authorization from Laos for its proprietary mRNA vaccine

SHANGHAI, Dec. 14, 2022 /PRNewswire/ -- On December 8, 2022, Stemirna Therapeutics Co., Ltd. (Stemirna), a Chinese biotech startup specialized inmRNA technology-based drug development, received an Emergency Use Authorization (EUA) from the Food and Drug Department under the Ministry of Health of ...

2022-12-15 12:27 3464

CGTN: How China strengthens vaccine cooperation to battle COVID-19

BEIJING, Dec. 15, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, the world has raced against time, battling the pandemic as it wreaked havoc across the globe. Developing safe and effective vaccines is one of the most crucial steps in the fight against the virus. For the last nearly three y...

2022-12-15 09:16 2370

Novavax Announces Proposed $125 Million Public Offering of Common Stock

GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwritten public offering to sell up to $125 million of its c...

2022-12-15 05:39 3199

Superior Results Of The Comparative Study Of The Company's Recombinant Two-Component COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine

TAIZHOU, China, Dec. 14, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results were achieved for its sequential booster vaccination Phase II study of the recombinant twocomponent COVID-19 ...

2022-12-14 15:17 3878

CGTN: 'New Approaches': Hospitals gear up to prioritize COVID-19 patients

BEIJING, Dec. 14, 2022 /PRNewswire/ -- To echo China's new guidelines for COVID-19 prevention and control, local governments and hospitals across the country have been optimizing medical services and the allocation of medical resources to face a likely surge in patients and take better care of th...

2022-12-14 12:36 2288

Fosun International Receives "ESG Leading Enterprise Award" and "ESG Leading Social Initiative Award" from Bloomberg Businessweek/Chinese Edition

HONG KONG, Dec. 14, 2022 /PRNewswire/ -- On 12 December 2022, the results of the fourth ESG Leading Enterprise Awards 2022, which was organized by the Chinese Edition of Bloomberg Businessweek in partnership with Deloitte, one of the world's largest accounting firms, and with the support from Inv...

2022-12-14 11:09 2873

CGTN: The Chinese are sharing their COVID experiences as policy optimized

BEIJING, Dec. 13, 2022 /PRNewswire/ -- Vincent Zhong is a Chinese digital gadget YouTuber with more than 372,000 followers. Aside from smartphones, earbuds and laptops, Zhong recently unboxed a special object: COVID-19. "I'm screwed," Zhong said in a video showing a positive COVID test result on ...

2022-12-13 12:49 2074

CGTN: Infrastructure, vaccines and space: China-Arab sci-tech cooperation

BEIJING, Dec. 12, 2022 /PRNewswire/ -- Under the Belt and Road Initiative (BRI), China-Arab cooperation in the fields of infrastructure, space and health has been continuously developed in a sustainable manner. China has vowed to ...

2022-12-12 15:39 2251

CGTN: Infrastructure, vaccines and space: China-Arab sci-tech cooperation

China further optimizes COVID-19 response with new measures

BEIJING, Dec. 12, 2022 /PRNewswire/ -- A report from People's Daily: Local authorities across China have soon made specific policies to implement the 10 new prevention and control measures recently rolled out by the country on further optimizing the COVID-19 response, so as to contain the epidemi...

2022-12-12 11:38 1917

China recalibrates its COVID-19 response strategy

BEIJING, Dec. 12, 2022 /PRNewswire/ -- After months of lining up every two to three days to take a nucleic acid test at temporary testing stations dotting the urban landscape, many Chinese residents were pleasantly surprised to learn onDecember 7 that they would no longer be required to take the ...

2022-12-12 10:22 1777

China recalibrates its COVID-19 response strategy

1 ... 3 4 567 8 9 ... 65